chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  COVID infections following completion of COVID vaccine series 01/20/21 COVID vaccine dose #1 02/10/21 COVID vaccine dose #2 04/21/21 Pt presents to ED reporting chest pain that intermittently radiates to left shoulder; EKG, NSR, troponin WNL, CXR WNL; treated with nitroglycerin and aspirin; admitted inpatient for monitoring 04/22/21 Pt was planned for discharge with increase doses of metoprolol to 50 and isosorbide to 60mg but then pt's blood pressure dropped to 90s/70s; isosorbide decreased to 30 mg 04/23/21 Pt discharged with changes to medications; metoprolol 25 mg and isosorbide 60 mg 06/19/21 Pt presents to ED reporting having chest pain in the bathroom and waking up on the floor; complaining of back pain from the fall; during the exam, it was found he had right sided deficits revealing possible stroke; admitted inpatient 06/20/21 Pt endorsed having increased dizziness post increase in isosorbide dose in Apr w/o any significant improvement in his chest pain; lisinopril and isosorbide dosage reduced; awaiting Neurology evaluation and ECHO to be performed 06/22/21 Pt discharged; advised to hold Lisinopril, tamsulosin 06/28/21 Pt reports acute on chronic lower back pain; given rx for tylenol, methocarbamol, and gabapentin 07/27/21 Pt presents to ED reporting flu-like symptoms with dry cough, body aches, fever, shortness of breath, wife recently tested positive; CXR WNL; treated with albuterol/ipratroprium, dexamethasone, acetaminophen; discharged home with rx for acetaminophen, albuterol, ascrobic acid. dexamethasone, cholecalciferol 07/28/21 Pt reports intractable hiccups and difficulty sleeping, chills, cough, fever, fatigue, loss of taste/smell, muscle pain, nausea, runny nose, sore throat that started 07/18 07/29/21 Pt reports symptoms resolved 07/30/21 Pt reports nausea in waves, and shortness of breath on exertion 07/31/21 Pt is improving and stable; clinically resolved
3 vaccines administered between 10:15 AM and 10:30 AM on 8-1-05. At 10:40 AM, client c/o 5 red, raised lesions on face and neck, 10-15mm in size. Also, c/o puritis. Denied SOB. Two Benadryl 25 mg. administered by mouth. At 11:00 AM lesions resolved. Client denies puritis and SOB. Bilateral lungs clear to  ascultation. Client departed health unit.
pt recv vax 11APR97;13APR97 exp temp elevation of 102-105.8 in the PM only;MD felt that vax had viral infect & that fevers (tx w/APAP) were not d/t vax;
Chest pain, cough, fatigue, and mucus. Til now i still have these effects but the doctors said they couldnt find anything
Received both doses of product and Parkinson's symptoms seem to have disappeared/a history of Parkinson's had improvement of his symptoms after the Pfizer covid vaccine, especially the second one.; This is a spontaneous report from a contactable nurse. This nurse reported for a male patient in his sixties 9 years (7-decade) that he received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: UNKNOWN) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history included Parkinsons. Concomitant medications were not reported. The patient also received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: UNKNOWN) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. On an unspecified date, it was reported that the patient received both doses of the product and for some reason his Parkinsons symptoms seem to have disappeared after getting the doses of the Covid vaccine, kind of intriguing. The reporter stated that, last time she saw the patient, he was very happy, held out his hands to show they were not shaking, his Parkinsons symptoms had not been happening at that time. She has no available information on the patient's vaccine and stated that she spoke with him on 08May2021 and that was when he mentioned that his Parkinson's symptoms had stopped since the vaccine. She does not know when the patient was diagnosed with Parkinsons disease. Report was related to a study or programme. Outcome of the event was unknown.  Follow-up (28Jun2021): This is a follow up spontaneous report from a Pfizer sponsored program support. A contactable nurse reported for a male patient which included patient medical comments.  Follow-up (01July2021): This is a follow up spontaneous report from a nurse. A contactable nurse reported for a male patient.  Follow-up (01Jul2021): This is a follow-up spontaneous report received from nurse. This nurse reported for a male patient via telephonic follow-up activity which included event details.  Information on the lot/ batch number has been requested.
I was on day 11 of my cycle, and had just stopped bleeding about 6 days before my first dose.  Within 30 minutes, I had abdominal cramping similar to the feeling of ovulation.  Then I started to bleed again.  It lasted for 2.5 days of spotting.  And it threw my cycle off.  I was 5 days late for my period this month and it is heavier than normal.
Client received Pfizer Dose 1 on 08/20/2021, and returned to vaccination site 09/10/2021 to receive second dose and complete Pfizer vaccination series. Database shows that client received a Janssen vaccination on 04/09/2021. Client attests that she did received the Janssen vaccine before her Pfizer, and sought out Pfizer under her doctor's orders.  Client did not receive second dose Pfizer today. Client was informed that mixing vaccines from different manufacturers is not recommended.
fever all night; body aches all night; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever all night) and MYALGIA (body aches all night) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PYREXIA (fever all night) and MYALGIA (body aches all night). At the time of the report, PYREXIA (fever all night) and MYALGIA (body aches all night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported. No treatment medication was reported.    Reporter did not allow further contact
20 min after vaccine administration, patient noted to be flushed, stated tongue and throat felt funny, early papular rash erupting.  Immediately given Epi 0.3cc IM, patient continued with chest tightness, additional Epi 0.3 cc and 125mg Solumedrol IM with eventual resolution of symptoms.  D/C home after 3 hours monitoring with EpiPen, tapering prednisone coarse, and instructions to take Claritin every day for next 14 days.
Per patient: "Hives" beginning on Left arm on 10/26/07, day after injection. Hives spread to other arm, then legs, over next 3 days. dx: urticaria, treatment: allegra D 24 hrs one by mouth daily x 10 days.
Chest pain with shortness of breath, headache, nausea, high blood pressure. Called 911; did EKG and ambulance showed was having heart attack. Had cardiac catheterization at hospital, showing heart attack in small vessel, likely caused by clot.
Myalgia, Arthralgia, Fever, ErythemaMultiform, fatigue Narrative:
No adverse effects reported.; improperly stored vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 09-SEP-2019, the patient was vaccinated with one improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, once, intramuscularly, lot # S002877, expiration date: 29-JAN-2021, for prophylaxis. Sterile diluent used to reconstitute the varicella virus vaccine live (oka/merck)(VARIVAX) was stored in the correct storage temperature range. The vaccine underwent temperature excursion of 8.1 degrees Fahrenheit for 20 minutes. There were previous temperature excursions of 8.1 degrees Fahrenheit for 17 minutes and 9.5 degrees Fahrenheit for 21 minutes. The digital data logger was involved in recording excursion details. No adverse effects were reported.
Vaccine logistician drew up 0.5 mL of Pfizer Bivalent instead of 0.3 mL, the 0.5 mL
Soreness at injection site for a day or two; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 44 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid right, administration date 11Jan2021 14:00 (Lot number: EL3249) at the age of 44 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "Soreness at injection site for a day or two". Additional information: The patient did not receive prior vaccination and had no relevant tests. She had no family medical history relevant to AE. The patient received dose 2 (Lot number: EM9810) on 01Feb2021 and dose 3 (Lot number: 33130BA) on 14Dec2021.  No follow-up attempts are possible. No further information is expected.
3 day after shot developed pain/weakness (L) arm/shoulder. c/o to able to lift self up into forklift due to weakness-treatment with aspirin/ VOLTAREN and called to f/u today-no better.
Patient's left arm is red, swelling and itchy. Patient also complained of some pain/soreness when she lifts her arm half way through above her head.
Fatigue and body aches 1/8/21 8:00 pm.  Severe chills and body aches 1/8/20 11:00 pm continued for several hours. Muscle and body aches and fatigue continued until 1/10/21 7:00 am was gone.  Swollen lymph nodes on neck (still experiencing this 1/12/21)
Dizziness, Headache,  fatigue, cognitive delay, anxiety tremors, injection site pain  Narrative:  tremors, fatigue, headache, dizziness, cognitive delay, pain at injection site after first dose given  Other Relevant History:
I experienced 24 hours after, significant fatigue and headache. As the day went on headache got worse. On 01-22-2021, I developed muscle aches as well and headaches were getting worse, started getting vertigo and felt dizzy. My vertigo was getting worse and continued for about 5 days and then my muscle aches were going away. On the following Tuesday went to see my PCP who gave me Dramamine (to take once a day)and to rest and by the following week my symptoms were getting better. By the last week of January I can say my headaches were also going away and I started to feel better.     I do not have lot # at the moment..
Patient called and reported that she had a reaction of dizziness shortly after the vaccine but after leaving my store. She took and antihistamine and had no further reactions.
non-raised red spots on/ top of both legs/ top of both feet to her toes/ top of both arms /are currently on /lower arms, torso, face and tongue; spots are itchy; vision is blurry currently.; spots are currently on her /tongue; she is allergic to the ingredients in the vaccine; sweating; chills; fever; This case was reported by a consumer via call center representative and described the occurrence of sweating in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included eczema.   On 4th March 2021, the patient received the 1st dose of Shingrix (intramuscular). On 4th March 2021, less than a day after receiving Shingrix, the patient experienced sweating, chills and fever. On 11th March 2021, the patient experienced red spotty rash, pruritus, blurred vision, rash tongue and allergy to vaccine. The patient was treated with prednisone and antihistamine. On 7th March 2021, the outcome of the sweating, chills and fever were recovered/resolved. On an unknown date, the outcome of the red spotty rash, pruritus, blurred vision and rash tongue were not recovered/not resolved and the outcome of the allergy to vaccine was unknown.   The reporter considered the sweating, chills, fever, red spotty rash, pruritus, blurred vision, rash tongue and allergy to vaccine to be related to Shingrix.  Additional details were provided as follows: The reporter reported after receiving her Shingrix vaccine she experienced sweating, chills, and fever that resolved in 3 days (did not share how soon they began after the vaccine).  The reporter stated that, on 11th March 2021, she began to break out in non-raised red spots on the top of both legs, the top of both feet to her toes, and the top of both arms. The reporter's HCP had put her on Prednisone dose packs which she had been on and off since 11th March 2021.  The reporter was currently maintained on Prednisone 10mg daily to keep the spots at bay. The spots were itchy and the prednisone helped with that and in addition to Prednisone she was taking an antihistamine.  The reporter also stated that, the spots went away when she was on the Prednisone dose pack, but when she finished the medication the spots reappeared in a different area. The spots were currently on her lower arms, torso, face and tongue.  The reporter stated her vision was blurry currently and she had been to her Healthcare professional, a dermatologist and an allergist.  The dermatologist performed a punch test and it came back as eczema was the cause of the rashes. The reporter does not think this was eczema. The allergist and Healthcare professional, said that this was a super auto immune response to the Shingrix vaccine.  The Healthcare professional did not recommend getting the second dose of Shingrix. The caller felt she was allergic to the ingredients in the vaccine. The reporter did not consent to follow up.
Body aches; dizziness; Mild injection sore pain; headache.; Dose received: 3; This is a spontaneous report from a contactable reporter (consumer or other non-HCP).   A 54-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in left arm, administration date 18Dec2021 at 12:30 (Lot number: FJ8757) at the age of 54 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Diabetic" (unspecified if ongoing); "Heart attack" (unspecified if ongoing), notes: past heart attack and "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19? Yes. Concomitant medications included: ASPIRIN; CARVEDILOL; ATORVASTATIN; CALCIUM; NOVOLOG; VIT D, VIT E and gummy vitamin (as reported). Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: EW0169, Route of Administration: intramuscular), administration date: 14Apr2021, when the patient was 54 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: EW0167, Route of administration: intramuscular, administration time: 12:00), administration date: 05May2021, when the patient was 54 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 18Dec2021 at 12:30, outcome "unknown", described as "Dose received: 3"; PAIN (non-serious) with onset 19Dec2021 at 06:30, outcome "recovering", described as "body aches"; DIZZINESS (non-serious) with onset 19Dec2021 at 06:30, outcome "recovering", described as "dizziness"; VACCINATION SITE PAIN (non-serious) with onset 19Dec2021 at 06:30, outcome "recovering", described as "mild injection sore pain"; HEADACHE (non-serious) with onset 19Dec2021 at 06:30, outcome "recovering", described as "headache". Therapeutic measures were not taken as a result of pain, dizziness, vaccination site pain and headache.  Additional Information: The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.
Information has been received from a 60 year old female consumer with 'allergies to some chemicals in perfumes' and a history of shingles in March 2008, who on  13-May-2009 was vaccinated with a 0.6ml dose of ZOSTAVAX (Merck) (lot number not reported). Concomitant therapy included estrogens, Premarin (dose, duration and indication not reported). Subsequently, early on the 14-May-2009, the patient experienced knot, redness and warmth to the touch at the injection site. The patient did not seek medical attention and there were no laboratory studies performed. At the time of report, the patient had not recovered. Additional information has been requested.
It hurt for about four days; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In JUL-2023, the patient received Shingles vaccine. In JUL-2023, less than a week after receiving Shingles vaccine, the patient experienced pain (Verbatim: It hurt for about four days). The outcome of the pain was resolved (duration 4 days).   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 10-Jul-2023 This case was reported the patient via interactive digital media. The patient got the follow up shot last week. The vaccine hurt for about 4 days. The reporter asked if the vaccine will be worth if the patient actually did  get shingles. Follow-up not possible as no contact details provided.
Patient called on 12/11/21 asking if we did first dose walk in appointments for COVID vaccines which I told her yes. She came in on 12/12/21 looking for a COVID vaccine. The pharmacy technician asked her if it was for a first dose or a booster and the patient confirmed it was a first dose. When I got into the room with her I also verified if this was a first dose for her, which she said yes, and she said she wanted to do Moderna. When I asked if she'd be doing her 2nd Moderna dose with us, she said yes, and I said I would be sure to schedule her follow up dose before she left. I then drew up the correct dose of 0.5ml as she said she was a first dose. When I went to document the dose administered, Database told me it was the wrong dose for her series. I went into her chart and then saw that she had been given one dose of Janssen vaccine on 4/8/21. When I asked her about that she said she forgot she had already received a COVID vaccine. I informed her that because of this I had given her an incorrect dose (it should have been 0.25ml since this actually would have been her booster) and that she would be ok, but that I would be sure to report this event. I also told her we would not be administering any more doses of Moderna as she had just received a booster for her Janssen vaccine, and thus no more doses are allowed.
This spontaneous prospective pregnancy report as received from a pharmacist refers to his wife, a 29 year old female patient. On 10-OCT-2013 the patient was preparing a dose of ZOSTAVAX (lot#, expiration date, dose, route, indication not reported) to administer to a patient, and accidently "pricked herself with the syringe". There was no concomitant medication, pertinent medical history or drug reactions/allergies. The patient became pregnant with LMP of 25-FEB-2013 ("7.5 months pregnant on reporting") and EDD of 02-DEC-2013. The patient had already contact gynaecology and obstetrics (OB/GYN). There was no treatment given for the event. No lab diagnostics studies performed. The pregnancy outcome was unknown. Additional information has been requested.
I experienced  exhaustion at work the following week, started losing weight, muscle fatigue/weakness, extreme headaches , dizziness, and has to go to the hospital on 09/12/2021 and they prescribed me a muscle relaxer which help relieve the chest pains. I was released after they performed a D-Dimer test because they didn't know what was happening to me.  I still continue to have issues and did not have any prior to the vaccine and am started to have issues concentrating or resting and none of the Doctors can determine why I'm continuing to have so many issues. I'm on disability leave until further notice awaiting on additional test results.
temperature elevated 1.5 degrees from normal; headaches; body aches; feeling of nausea; fatigue; 3rd (booster) dose.; This is a spontaneous report from a contactable consumer (Patient). A 65-year-old non pregnant female patient received third dose of (BOOSTER) BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: FF2590) via an unspecified route of administration in Arm Right on 12Oct2021 10:00 (age at vaccination 65- years-old) as single dose for covid-19 immunisation.The patient was not pregnant at the time of vaccination. Medical history includes known allergies with slight allergy to raw egg, some pollens, lanolin from an unknown date and unknown if ongoing. Concomitant medication included chlorpheniramine maleate (CHLORPHENIRAMINE MALEATE) taken for an unspecified indication received within 2 weeks of vaccination. The patient historical vaccines includes bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EP7534) via an unspecified route of administration, administered in Arm Right on 03Apr2021 10:45 as DOSE 2, SINGLE and bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6199) via an unspecified route of administration, administered in Arm Right on 13Mar2021 11:45 (age at vaccination 65- years-old)as DOSE 1, SINGLE for covid-19 immunisation and No adverse effects from first two doses. Patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. On 13Oct2021 at 07:00, patient experienced temperature elevated 1.5 degrees from normal with headaches and body aches and feeling of nausea and fatigue. No treatment received for adverse effect. patient has stated that she had not been diagnosed with COVID -19 prior to vaccination and not been tested since the vaccination. Patient was not affected with Covid prior to vaccination. The patient underwent lab tests and procedures which included body temperature increased:1.5 degree on 13Oct2021 elevated 1.5 degrees from normal. The clinical outcome of the events was recovered on an unspecified date of 2021.  Follow-up attempts are completed. No further information is expected.